Showing results (2321-2330 of 5,939) with videos related to

Sort By:
Pageof 594
The Prostate|November 11, 2009
Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasiaKazutoshi Fujita, Charles M Ewing, Robert H Getzenberg, et al.
The Prostate|November 11, 2009
Antagonistic interaction between bicalutamide (Casodex) and radiation in androgen-positive prostate cancer LNCaP cellsLaurent Quéro, Nicole Giocanti, Christophe Hennequin, et al.
The Prostate|November 11, 2009
Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African AmericansStanley Hooker, Wenndy Hernandez, Hankui Chen, et al.
The Prostate|December 24, 2005
Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinomaKlaus Brasso, Ib Jarle Christensen, Julia S Johansen, et al.
The Prostate|December 24, 2005
PAC1-R null isoform expression in human prostate cancer tissueCaterina Mammi, Giovanni V Frajese, Giuseppe Vespasiani, et al.
The Prostate|April 23, 2002
Differentiation and stromal-induced growth promotion of murine prostatic tumorsSarah N Salm, Tetsuya Takao, Akira Tsujimura, et al.
The Prostate|April 23, 2002
CAG polymorphic repeat lengths in androgen receptor gene among Japanese prostate cancer patients: potential predictor of prognosis after endocrine therapyHiroyoshi Suzuki, Koichiro Akakura, Akira Komiya, et al.
The Prostate|May 15, 1997
Histologic differences in benign prostate hyperplasia between Chinese and American menE Y Yu, J A Siegal, G E Meyer, et al.
The Prostate|May 15, 1997
Role of finasteride in the treatment of recurrent hematuria secondary to benign prostatic hyperplasiaB I Carlin, D R Bodner, J P Spirnak, et al.
The Prostate|May 15, 1997
Possible bone-preserving capacity of high-dose intramuscular depot estrogen as compared to orchidectomy in the treatment of patients with prostatic carcinomaK Carlström, R Stege, P Henriksson, et al.
Pageof 594